Cassava sciences announces expansion of leadership team

Austin, texas, oct. 27, 2022 (globe newswire) -- cassava sciences, inc. (nasdaq: sava), a clinical-stage biotechnology company focused on alzheimer's disease, announced the expansion of its leadership team with the appointment of christopher cook as senior vice president and general counsel. this is a newly created position, reporting to remi barbier, president & ceo.
SAVA Ratings Summary
SAVA Quant Ranking